dc.contributor.author |
Cabanillas Amado, Billy Joel |
|
dc.contributor.author |
Le Lamer, A.-C. |
|
dc.contributor.author |
Castillo Pareja, Denis Helan |
|
dc.contributor.author |
Arévalo Zelada, Jorge Luis |
|
dc.contributor.author |
Estevez, Y. |
|
dc.contributor.author |
Rojas, R. |
|
dc.contributor.author |
Valadeau, C. |
|
dc.contributor.author |
Bourdy, G. |
|
dc.contributor.author |
Sauvain, Michel Henri Auguste |
|
dc.contributor.author |
Fabre, N. |
|
dc.date.accessioned |
2022-01-18T19:26:50Z |
|
dc.date.available |
2022-01-18T19:26:50Z |
|
dc.date.issued |
2012 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/10922 |
|
dc.description.abstract |
Two new dihydrochalcones, as well as eight known compounds, piperaduncin C, 2,6-dihydroxy-4-methoxydihydrochalcone, 4,2,6-trihydroxy-4-methoxydihydrochalcone, 4-hydroxy-3,5-bis(3-methyl-2- butenyl)-benzoic acid, 3,5-bis(3-methyl-2-butenyl)-4-methoxybenzoic acid, 4-hydroxy-3-(3-methyl-2-butenoyl)-5-(3-methyl-2-butenyl)-benzoic acid, 2,2-dimethyl-8-(3-methyl-2-butenyl)-2H-1-chromene-6-carboxylic acid, and 3-(3,7-dimethyl-2,6-octadienyl)-4-methoxybenzoic acid were isolated from the leaves of Piper dennisii Trelease (Piperaceae), using a bioassay-guided fractionation to determine their antileishmanial potential. Among them, compound 10 exhibited the best antileishmanial activity (IC= 20.8 M) against axenic amastigote forms of Leishmania amazonensis, with low cytotoxicity on murine macrophages. In the intracellular macrophage-infected model, compound 10 proved to be more active (IC= 4.2 M). The chemical structures of compounds 1-10 were established based on the analysis of the spectroscopic data. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Georg Thieme Verlag |
|
dc.relation.ispartofseries |
Planta Medica |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Controlled Study |
en_US |
dc.subject |
Animal Cell |
en_US |
dc.subject |
Amastigote |
en_US |
dc.subject |
Disease Model |
en_US |
dc.subject |
Macrophage |
en_US |
dc.subject |
Leishmania |
en_US |
dc.subject |
Plant Extract |
en_US |
dc.subject |
Amphotericin B |
en_US |
dc.subject |
Drug Isolation |
en_US |
dc.subject |
Molecular Structure |
en_US |
dc.subject |
Plant Leaf |
en_US |
dc.subject |
Cytotoxicity |
en_US |
dc.subject |
Drug Structure |
en_US |
dc.subject |
Murinae |
en_US |
dc.subject |
Antiprotozoal Agents |
en_US |
dc.subject |
IC 50 |
en_US |
dc.subject |
Leishmania Amazonensis |
en_US |
dc.subject |
Antileishmanial Agent |
en_US |
dc.subject |
Drug Activity |
en_US |
dc.subject |
Chalcone Derivative |
en_US |
dc.subject |
Chalcones |
en_US |
dc.subject |
Inhibitory Concentration 50 |
en_US |
dc.subject |
Macrophages Peritoneal |
en_US |
dc.subject |
Bioassay |
en_US |
dc.subject |
Fractionation |
en_US |
dc.subject |
Spectroscopy |
en_US |
dc.subject |
Piperaceae |
en_US |
dc.subject |
Piper |
en_US |
dc.subject |
Chemical Structure |
en_US |
dc.subject |
22 Dimethyl 8 (3 Methyl 2 Butenyl) 2h 1 Chromene 6 Carboxylic Acid |
en_US |
dc.subject |
2'6' Dihydroxy 4' Methoxydihydrochalcone |
en_US |
dc.subject |
3 (3'7' Dimethyl 2'6' Octadienyl) 4 Methoxybenzoic Acid |
en_US |
dc.subject |
35 Bis(3 Methyl 2 Butenyl) 4 Methoxybenzoic Acid |
en_US |
dc.subject |
4 Hydroxy 3 (3 Methyl 2 Butenoyl) 5 (3 Methyl 2 Butenyl)Benzoic Acid |
en_US |
dc.subject |
4 Hydroxy 35 Bis(3 Methyl 2 Butenyl)Benzoic Acid |
en_US |
dc.subject |
42'6' Trihydroxy 4' Methoxydihydrochalcone |
en_US |
dc.subject |
Antileishmanial Activities |
en_US |
dc.subject |
Benzoic Acid Derivative |
en_US |
dc.subject |
Benzoic Acids |
en_US |
dc.subject |
Dihydrochalcones |
en_US |
dc.subject |
Drug Evaluation Preclinical |
en_US |
dc.subject |
Piper (Plant) |
en_US |
dc.subject |
Piper Dennisii|Piperaduncin C |
en_US |
dc.title |
Dihydrochalcones and benzoic acid derivatives from piper dennisii |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1055/s-0031-1298459 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.01.00 |
|
dc.relation.issn |
1439-0221 |
|